SlideShare uma empresa Scribd logo
1 de 4
Aarkstore.com announces- 20% Discount on This Report till 31st October
2012.

Refining Industry to 2017 - Asia-Pacific, Middle East and
Africa to Emerge as Key Regions for Infrastructure
Investments for Capacity Additions




You can also request for sample page of above mention reports on
sample@aarkstore.com




Summary

GBI Research, a leading business intelligence provider, has released its latest
research, “Refining Industry to 2017 - Asia-Pacific, Middle East and Africa to Emerge
as Key Regions for Infrastructure Investments for Capacity Additions”. The study,
which is an offering from the company’s Energy Research Group, provides an in-
depth analysis of the global refining industry, and highlights various concerns, key
trends and challenges across the industry. The report provides detailed information
and analysis on refining capacities by region and leading countries, upcoming
refineries and capacity expansions, market shares of key companies and competitive
scenarios in the global refining market to 2017.

Scope

- Detailed information and analysis on refining capacities by region and leading
countries, upcoming refineries and capacity expansions, market shares of key
companies, and competitive scenarios in the global refining market to 2017
Reasons to buy

- Develop business strategies with the help of specific insights about the global
refining industry.
- Identify key trends and challenges in the global and regional refining industry.


Table of contents:

1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 11
3 Global Refining Industry 12
3.1 Industry Overview 12
3.2 Global Refining Industry Growth, 2000–2017 15
3.3 Global Refining Capacity and Petroleum Product Demand 17
3.4 Global Refining Industry Market Share Analysis 19
3.5 Global Refining Industry: Key Trends and Challenges 20
3.5.1 Global Refining Industry, Major Trends 20
3.6 Global Refining – Factors Challenging Future Growth 23
3.6.1 Environment Regulatory Issues and High Investment Costs 23
3.6.2 New Capabilities Required to Process Heavy-sour Crude 23
3.7 Refinery Costs and Margins 23
3.7.1 Gross Refining Margins Overview 23
3.7.2 Gross Refining Margins Trends 24
3.7.3 Gross Refining Margins Trends, US Gulf Coast, 2009 – Q1 2012 24



List of Figures

List of Tables are also include.




For more Discounted Reports Plz follow The links:


Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive
Procedures and Reimbursement for New Indications to Increase Uptake
Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving
Quality Standards Build Confidence and Encourage Foreign Investment in Asian
CMOs

Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight
Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication
Remains a Challenge

Regulatory Intelligence on Medical Device Recalls - Ineffective Process Control,
Defects in Design of Device, Software or Other Components are the Major Reasons
for Recall

Refining Industry to 2017 - Asia-Pacific, Middle East and Africa to Emerge as Key
Regions for Infrastructure Investments for Capacity Additions



Search More Reports Related to This Category :


Medical Equipment
http://www.aarkstore.com/market-sector-reports/Devices-209.html




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com
Refining industry to 2017   asia-pacific, middle east

Mais conteúdo relacionado

Mais de Rose088

Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricantsRose088
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asiaRose088
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchRose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Rose088
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Rose088
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 

Mais de Rose088 (20)

Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 

Refining industry to 2017 asia-pacific, middle east

  • 1. Aarkstore.com announces- 20% Discount on This Report till 31st October 2012. Refining Industry to 2017 - Asia-Pacific, Middle East and Africa to Emerge as Key Regions for Infrastructure Investments for Capacity Additions You can also request for sample page of above mention reports on sample@aarkstore.com Summary GBI Research, a leading business intelligence provider, has released its latest research, “Refining Industry to 2017 - Asia-Pacific, Middle East and Africa to Emerge as Key Regions for Infrastructure Investments for Capacity Additions”. The study, which is an offering from the company’s Energy Research Group, provides an in- depth analysis of the global refining industry, and highlights various concerns, key trends and challenges across the industry. The report provides detailed information and analysis on refining capacities by region and leading countries, upcoming refineries and capacity expansions, market shares of key companies and competitive scenarios in the global refining market to 2017. Scope - Detailed information and analysis on refining capacities by region and leading countries, upcoming refineries and capacity expansions, market shares of key companies, and competitive scenarios in the global refining market to 2017
  • 2. Reasons to buy - Develop business strategies with the help of specific insights about the global refining industry. - Identify key trends and challenges in the global and regional refining industry. Table of contents: 1.1 List of Tables 8 1.2 List of Figures 9 2 Introduction 11 3 Global Refining Industry 12 3.1 Industry Overview 12 3.2 Global Refining Industry Growth, 2000–2017 15 3.3 Global Refining Capacity and Petroleum Product Demand 17 3.4 Global Refining Industry Market Share Analysis 19 3.5 Global Refining Industry: Key Trends and Challenges 20 3.5.1 Global Refining Industry, Major Trends 20 3.6 Global Refining – Factors Challenging Future Growth 23 3.6.1 Environment Regulatory Issues and High Investment Costs 23 3.6.2 New Capabilities Required to Process Heavy-sour Crude 23 3.7 Refinery Costs and Margins 23 3.7.1 Gross Refining Margins Overview 23 3.7.2 Gross Refining Margins Trends 24 3.7.3 Gross Refining Margins Trends, US Gulf Coast, 2009 – Q1 2012 24 List of Figures List of Tables are also include. For more Discounted Reports Plz follow The links: Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake
  • 3. Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge Regulatory Intelligence on Medical Device Recalls - Ineffective Process Control, Defects in Design of Device, Software or Other Components are the Major Reasons for Recall Refining Industry to 2017 - Asia-Pacific, Middle East and Africa to Emerge as Key Regions for Infrastructure Investments for Capacity Additions Search More Reports Related to This Category : Medical Equipment http://www.aarkstore.com/market-sector-reports/Devices-209.html For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com